Business Context and Reporting Period
This Form 8-K, filed on February 24, 2015, reports the completion of the acquisition of MWI Veterinary Supply, Inc. ("MWI") by AmerisourceBergen Corporation (now Cencora, Inc.). The transaction was executed pursuant to a Merger Agreement dated January 11, 2015, following a tender offer that expired on February 23, 2015.
Key Financial Metrics and Transaction Details
- Aggregate Consideration: Approximately $2.5 billion (excluding transaction fees and expenses).
- Purchase Price: $190.00 per share in cash, net to the seller.
- Shares Tendered: 10,096,484 shares (approximately 78.1% of outstanding shares).
- Guaranteed Delivery: 882,210 shares (approximately 6.8% of outstanding shares).
- Funding Sources: A combination of available cash on hand, proceeds from a Term Loan, and proceeds from the sale of Notes.
Material Changes and Transaction Completion
On February 24, 2015, the Purchaser (Roscoe Acquisition Corp.) merged with and into MWI under Section 251(h) of the Delaware General Corporation Law. MWI is now a wholly owned direct subsidiary of AmerisourceBergen. All outstanding shares of MWI were converted into the right to receive the Offer Price, except for treasury stock and shares held by stockholders exercising appraisal rights. MWI shares are no longer listed on the NASDAQ Global Select Market.
Outlook, Risks, and Management Commentary
The filing confirms that the Minimum Tender Condition and all other conditions to the Offer were satisfied. Management notes that the transaction was funded through a mix of internal liquidity and external financing (Term Loan and Notes). The filing incorporates press releases regarding the expiration of the offer and the completion of the acquisition but does not provide specific forward-looking guidance or risk factors within this specific text.
Investor Verification Checklist
- Verify the total transaction cost including related fees and expenses, as the $2.5 billion figure excludes these costs.
- Review the terms of the Term Loan and Notes issued to fund the acquisition for interest rates and maturity dates.
- Confirm the number of shares held by stockholders who demanded appraisal rights, as these shares were not converted to cash immediately.
- Examine the full Merger Agreement (Exhibit 2.1) for detailed representations, warranties, and indemnification provisions.